If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Ioxus intellectual property judgement

7 Aug 2020 15:18

RNS Number : 5477V
CAP-XX Limited
07 August 2020
 

 

 

7 August 2020

 

 

CAP-XX Limited

("CAP-XX" or the "Company")

 

Ioxus intellectual property judgement

 

CAP-XX Limited, a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems, announces that the Delaware District Court has made a judgment in favour of CAP-XX against Ioxus, Inc ("Ioxus").

The Court found that Ioxus is liable for infringing the patents-in-suit and awarded CAP-XX compensatory damages of $1,237,717 and enhanced damages of $3,713,152 and also awarded CAP-XX its attorney's fees.

CAP-XX intends to vigorously pursue the recovery of these awards, though it is unclear at this time whether this will be successful.

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

Allenby Capital (Nominated Adviser and Broker)

David Hart / Alex Brearley +44 (0) 20 3328 5656

 

 

More information is available at www.cap-xx.com

 

Notes to Editors:

 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUBASRRSUWRAR

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS